These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2332248)

  • 1. Selection of antibiotics for treatment and prophylaxis of staphylococcal infections in cystic fibrosis patients.
    Bauernfeind A; Przyklenk B; Matthias C; Jungwirth R; Bertele RM; Harms K
    Infection; 1990; 18(2):126-30. PubMed ID: 2332248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
    Champion EA; Miller MB; Popowitch EB; Hobbs MM; Saiman L; Muhlebach MS;
    Pediatr Pulmonol; 2014 Mar; 49(3):230-7. PubMed ID: 23765686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Staphylococcus aureus in cystic fibrosis.
    Elborn JS
    Thorax; 1999 May; 54(5):377-8. PubMed ID: 10212096
    [No Abstract]   [Full Text] [Related]  

  • 5. Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients.
    Hill RL; Kearns AM; Nash J; North SE; Pike R; Newson T; Woodford N; Calver R; Livermore DM
    J Antimicrob Chemother; 2010 Mar; 65(3):442-5. PubMed ID: 20089543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotic treatment of cystic fibrosis exacerbations].
    Dumcius S
    Medicina (Kaunas); 2003; 39(3):221-4. PubMed ID: 12695633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.
    Heltshe SL; Saiman L; Popowitch EB; Miller MB; Kloster M; Thompson V; Ferkol TW; Hoover WC; Schechter MS; Muhlebach MS
    J Pediatric Infect Dis Soc; 2015 Sep; 4(3):225-31. PubMed ID: 26336603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
    Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
    Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre.
    Morelli P; De Alessandri A; Manno G; Marchese A; Bassi M; Lobello R; Minicucci L; Bandettini R
    New Microbiol; 2015 Apr; 38(2):235-43. PubMed ID: 25938748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Zobell JT; Epps KL; Young DC; Montague M; Olson J; Ampofo K; Chin MJ; Marshall BC; Dasenbrook E
    Pediatr Pulmonol; 2015 Jun; 50(6):552-9. PubMed ID: 25559432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review.
    Castagnola E; Cangemi G; Mesini A; Castellani C; Martelli A; Cattaneo D; Mattioli F
    Int J Antimicrob Agents; 2021 Sep; 58(3):106381. PubMed ID: 34157401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.
    Suwantarat N; Rubin M; Bryan L; Tekle T; Boyle MP; Carroll KC; Jennings MT
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):296-299. PubMed ID: 29343421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.
    Bauernfeind A; Emminger G; Hörl G; Ott S; Przyklenk B; Weisslein-Pfister C
    Infection; 1987; 15(5):403-6. PubMed ID: 3121519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis.
    Elizur A; Orscheln RC; Ferkol TW; Atkinson JJ; Dunne WM; Buller RS; Armstrong JR; Mardis ER; Storch GA; Cannon CL
    Chest; 2007 Jun; 131(6):1718-25. PubMed ID: 17400676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problems of antibiotic therapy in mucoviscidosis].
    Steinitz H
    Z Allgemeinmed; 1972 Aug; 48(24):1085-9. PubMed ID: 4649651
    [No Abstract]   [Full Text] [Related]  

  • 18. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
    Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
    Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis.
    Szaff M; Høiby N
    Acta Paediatr Scand; 1982 Sep; 71(5):821-6. PubMed ID: 7180452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Li Y; Zhang X; Wang C; Hu Y; Niu X; Pei D; He Z; Bi Y
    Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.